Health
QIAGEN Highlights Newly Published Data Supporting Efficacy of QuantiFERON for TB Prevention
GERMANTOWN, Md. & VENLO, Netherlands, March 19, 2026--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced newly published clinical and health economic data supporting the use of its QuantiFERON-TB Gold Plus (QFT-Plus) blood test for detecting tuberculosis (TB) infection, particularly in immunocompromised and other high-risk populations.
About this update from Qiagen N.v.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":242,"height":204,"url":"https://media.zenfs.com/en/business-wire.com/f28f0e6e69818767246556c1cb45837f"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/yvDLhqSN2sUpN2IZCS89TA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTM1NA--/https://media.zenfs.com/en/business-wire.com/f28f0e6e69818767246556c1cb45837f","width":242,"height":204}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"New study supports QuantiFERON-TB Gold Plus use in immunocompromised and other high-risk populations in various settings","length":120,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Findings show QuantiFERON testing is cost-effective compared with tuberculin skin testing in people living with HIV","length":115,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"CPD-accredited online QuantiFERON World TB Day program on March 24 convenes global experts to advance TB detection, prevention and high-impact scientific exchange","length":162,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":397,"olType":false},{"type":"text","content":"GERMANTOWN, Md. & VENLO, Netherlands, March 19, 2026--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced newly published clinical and health economic data supporting the use of its QuantiFERON-TB Gold Plus (QFT-Plus) blood test for detecting tuberculosis (TB) infection, particularly in immunocompromised and other high-risk populations.","length":379,"tagName":"p"},{"type":"text","content":"The announcement is being made in time for World TB Day to underscore the continued importance of improving TB detection and prevention globally. The global QuantiFERON World TB Day event will take place online on March 24, 2026, with two identical sessions to enable participation across regions. To learn more and reserve a free spot, visit https://worldtbday.qiagen.com/.","length":374,"tagName":"p"},{"type":"text","content":"A study recently published in BMC Public Health evaluated TB infection screening strategies among adults living with HIV in Thailand and found that QFT-Plus testing reduced the modeled lifetime risk of progression to active TB by 41% compared with the tuberculin skin test (TST), whil...